Merck snags Chinese obesity drug in nearly $2 billion deal
- Posted on December 19, 2024
- By Fortune
- 2 Views
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors.
